163 related articles for article (PubMed ID: 21128594)
1. Development of potent μ and δ opioid agonists with high lipophilicity.
Lee YS; Kulkarani V; Cowell SM; Ma SW; Davis P; Hanlon KE; Vanderah TW; Lai J; Porreca F; Vardanyan R; Hruby VJ
J Med Chem; 2011 Jan; 54(1):382-6. PubMed ID: 21128594
[TBL] [Abstract][Full Text] [Related]
2. Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.
Lee YS; Petrov R; Park CK; Ma SW; Davis P; Lai J; Porreca F; Vardanyan R; Hruby VJ
J Med Chem; 2007 Nov; 50(22):5528-32. PubMed ID: 17927164
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.
Yamamoto T; Nair P; Davis P; Ma SW; Navratilova E; Moye S; Tumati S; Lai J; Vanderah TW; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 2007 Jun; 50(12):2779-86. PubMed ID: 17516639
[TBL] [Abstract][Full Text] [Related]
4. Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2.
Li T; Fujita Y; Tsuda Y; Miyazaki A; Ambo A; Sasaki Y; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y
J Med Chem; 2005 Jan; 48(2):586-92. PubMed ID: 15658871
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.
Agnes RS; Lee YS; Davis P; Ma SW; Badghisi H; Porreca F; Lai J; Hruby VJ
J Med Chem; 2006 May; 49(10):2868-75. PubMed ID: 16686530
[TBL] [Abstract][Full Text] [Related]
6. Orally active opioid μ/δ dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice.
Matsumoto K; Narita M; Muramatsu N; Nakayama T; Misawa K; Kitajima M; Tashima K; Devi LA; Suzuki T; Takayama H; Horie S
J Pharmacol Exp Ther; 2014 Mar; 348(3):383-92. PubMed ID: 24345467
[TBL] [Abstract][Full Text] [Related]
7. A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.
Yamamoto T; Nair P; Vagner J; Largent-Milnes T; Davis P; Ma SW; Navratilova E; Moye S; Tumati S; Lai J; Yamamura HI; Vanderah TW; Porreca F; Hruby VJ
J Med Chem; 2008 Mar; 51(5):1369-76. PubMed ID: 18266313
[TBL] [Abstract][Full Text] [Related]
8. The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.
Mollica A; Pinnen F; Stefanucci A; Feliciani F; Campestre C; Mannina L; Sobolev AP; Lucente G; Davis P; Lai J; Ma SW; Porreca F; Hruby VJ
J Med Chem; 2012 Apr; 55(7):3027-35. PubMed ID: 22394120
[TBL] [Abstract][Full Text] [Related]
9. Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties.
Fujita Y; Tsuda Y; Li T; Motoyama T; Takahashi M; Shimizu Y; Yokoi T; Sasaki Y; Ambo A; Kita A; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y
J Med Chem; 2004 Jul; 47(14):3591-9. PubMed ID: 15214786
[TBL] [Abstract][Full Text] [Related]
10. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligands.
Li T; Shiotani K; Miyazaki A; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Lazarus LH; Okada Y
J Med Chem; 2007 Jun; 50(12):2753-66. PubMed ID: 17497839
[TBL] [Abstract][Full Text] [Related]
12. Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.
Deekonda S; Cole J; Sunna S; Rankin D; Largent-Milnes TM; Davis P; BassiriRad NM; Lai J; Vanderah TW; Porecca F; Hruby VJ
Bioorg Med Chem Lett; 2016 Jan; 26(1):222-7. PubMed ID: 26611918
[TBL] [Abstract][Full Text] [Related]
13. From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH.
Balboni G; Cocco MT; Salvadori S; Romagnoli R; Sasaki Y; Okada Y; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2005 Aug; 48(17):5608-11. PubMed ID: 16107162
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists.
Lee YS; Agnes RS; Badghisi H; Davis P; Ma SW; Lai J; Porreca F; Hruby VJ
J Med Chem; 2006 Mar; 49(5):1773-80. PubMed ID: 16509592
[TBL] [Abstract][Full Text] [Related]
15. Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists.
Li T; Fujita Y; Shiotani K; Miyazaki A; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Salvadori S; Lazarus LH; Okada Y
J Med Chem; 2005 Dec; 48(25):8035-44. PubMed ID: 16335927
[TBL] [Abstract][Full Text] [Related]
16. Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists.
Yamamoto T; Nair P; Jacobsen NE; Vagner J; Kulkarni V; Davis P; Ma SW; Navratilova E; Yamamura HI; Vanderah TW; Porreca F; Lai J; Hruby VJ
J Med Chem; 2009 Aug; 52(16):5164-75. PubMed ID: 20560643
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.
Balboni G; Guerrini R; Salvadori S; Bianchi C; Rizzi D; Bryant SD; Lazarus LH
J Med Chem; 2002 Jan; 45(3):713-20. PubMed ID: 11806723
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A
J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203
[TBL] [Abstract][Full Text] [Related]
19. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands.
Rew Y; Malkmus S; Svensson C; Yaksh TL; Chung NN; Schiller PW; Cassel JA; DeHaven RN; Taulane JP; Goodman M
J Med Chem; 2002 Aug; 45(17):3746-54. PubMed ID: 12166947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
